johnson & johnson

  1. syamfx2020

    Why J&J stock slips despite strong Q3 earnings

    Johnson & Johnson (NYSE: JNJ) reported better-than-expected third-quarter financial results on Tuesday. The drugmaker raised its full-year guidance, saying it now expects per-share earnings of between $7.95 and $8.05, up from its previous forecast in July of between $7.75 and $7.95. "Our...
Top